Tg Therapeutics TGTX
NASDAQ TGTX
$56.74 +0.55 (+0.98%)
As of: Sep 30, 2026 · 2:09 PM EDT

Tg Therapeutics, Inc. (TGTX) Raw Materials (2023 - 2025)

Updated

Tg Therapeutics (TGTX) reported Raw Materials of $4.06 million for Q3 2025, up 134.1% from $1.73 million a year earlier but down 1.5% from the prior quarter.

Analysis

Tg Therapeutics, Inc. (TGTX) Raw Materials (2023 - 2025) Analysis & Trends

At the end of FY2024, Tg Therapeutics posted Raw Materials of $28.15 million, up 327.7% from FY2023.

  • By year, Raw Materials came in at $6.58 million in FY2023.
  • Five-year quarterly Raw Materials spans a low of $24,000 in Q1 2023 and a high of $28.15 million in Q4 2024.
  • Year over year, Raw Materials has now increased in each of the last five quarters, with growth averaging 156.2% over the last five quarters.
  • Per Business Quant data, the three quarters before Q3 2025 came in at $4.12 million (Q2 2025), $4.12 million (Q1 2025) and $28.15 million (Q4 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 4.06 Mn
Jun 30, 2025 4.12 Mn
Mar 31, 2025 4.12 Mn
Dec 31, 2024 28.15 Mn
Sep 30, 2024 1.73 Mn
Jun 30, 2024 1.74 Mn
Mar 31, 2024 1.71 Mn
Dec 31, 2023 6.58 Mn
Sep 30, 2023 1.23 Mn
Jun 30, 2023 24,000.00
Mar 31, 2023 24,000.00
API Access

Tg Therapeutics, Inc. Raw Materials API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=raw-materials&ticker=TGTX&period=max&api_key=YOUR_API_KEY